☆ 4.7 Article

A novel inhibitor of oxidosqualene: Lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (ApoB100) production and enhances low-density lipoprotein ApoB100 catabolism through marked reduction in hepatic cholesterol content

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

A novel inhibitor of oxidosqualene: Lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (ApoB100) production and enhances low-density lipoprotein ApoB100 catabolism through marked reduction in hepatic cholesterol content

Rate this paper

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer

Export Citation

Share Paper